Live Breaking News & Updates on Spotlighting Hazards

January’s Dermatology Month in Review features 2 major FDA decisions, positive results on a new assessment tool, an evaluation of climate change’s impact on eczema, and more. ....

Markd Kaufmann , Katrina Abuabara , Ligand Pharmaceuticals Inc , Regeneron Pharmaceuticals Inc , Drug Administration , Icahn School Of Medicine At Mount Sinai , University Of California San Francisco , Bruce Strober At Yale University , Winter Clinical , Topical Berdazimer Gel Announced , Ligand Pharmaceuticals , Icahn School , Mount Sinai , Term Efficacy , Risankizumab Observed , Psoriasis Regardless , Bruce Strober , Yale University , Patient Reported Assessment Tool Validated , Prurigo Control Test , Spotlighting Hazards , California San Francisco , Atopic Dermatitis ,